CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit

First Page		Document Content
Date: 2016-06-03 12:14:22 Chemistry Organic chemistry Clinical medicine Lung cancer Quinazolines Tyrosine kinase receptors Tyrosine kinase inhibitors Amines Brigatinib Gefitinib T790M Non-small-cell lung carcinoma		CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit Add to Reading List Source URL: gotoper-com.s3.amazonaws.com Download Document from Source Website File Size: 236,30 KB Share Document on Facebook

	Citation: Molecular Therapy—Nucleic Acids, e150; doi:mtna © 2014 The American Society of Gene & Cell Therapy All rights reservedwww.nature.com/mtna Overcoming EGFR T790M-bas DocID: 1remk - View Document
	CME A Look at the Near Future of Lung Cancer Treatment Dates of certification: May 31, 2016, to May 31, 2017 Medium: Print with online posttest, evaluation, and request for credit DocID: 1qVsW - View Document
	ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced DocID: 1qm1i - View Document
	Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016 DocID: 1pw0y - View Document
	TAGRISSO (osimertinib) tablet, for oral use DocID: 1p2Iq - View Document